Plasma Therapeutics Market Size, Share, Trends, Growth Outlook

Plasma Therapeutics Market is estimated to increase at a growth rate of 6.8% CAGR over the forecast period from 2024 to 2030.

The global Plasma Therapeutics Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Immunoglobulin, Albumin, Blood Factors, Others).

An Introduction to Plasma Therapeutics Market in 2024

The Plasma Therapeutics Market in 2024 encompasses a diverse range of biopharmaceutical products derived from human plasma, offering life-saving therapies for patients with rare and chronic diseases, immune deficiencies, and coagulation disorders. Plasma therapeutics include plasma-derived proteins such as immunoglobulins, coagulation factors, albumin, and alpha-1 antitrypsin, as well as recombinant products produced through biotechnology, utilized for the treatment of conditions including primary immunodeficiency diseases, hemophilia, alpha-1 antitrypsin deficiency, and neurological disorders. With increasing demand for plasma-derived therapies, advancements in manufacturing technology, and expanding clinical indications, the plasma therapeutics market witnesses sustained growth and innovation, driven by factors such as rising prevalence of chronic diseases, growing patient awareness, and improving healthcare infrastructure. Moreover, as stakeholders collaborate to ensure a safe and secure plasma supply chain, expand plasma collection capacity, and advance research into new therapeutic applications, the plasma therapeutics market plays a vital role in addressing unmet medical needs and improving patient outcomes across diverse therapeutic areas.

Plasma Therapeutics Market Competitive Landscape

The global Plasma Therapeutics Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Plasma Therapeutics Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Plasma Therapeutics Industry include- ADMA Biologics Inc, Bio Products Laboratory Ltd, BIOPHARMA PLASMA, CSL Ltd, Emergent BioSolutions Inc, Evolve Biologics Inc, Grifols SA, Kamada Ltd, Kedrion Spa, Octapharma AG, Pfizer Inc, Prothya Biosolutions Netherlands BV, SK Discovery Co. Ltd, Takeda Pharmaceutical Co. Ltd.

Plasma Therapeutics Market Trend: Advancements in Plasma Fractionation Techniques

Advancements in plasma fractionation techniques are driving innovation within the Plasma Therapeutics market. Plasma, the liquid portion of blood containing proteins, antibodies, and other therapeutic factors, serves as a valuable source for the production of plasma-derived therapeutics used in the treatment of various medical conditions. Recent developments in fractionation technologies, such as chromatography, ultrafiltration, and viral inactivation methods, have enhanced the efficiency, purity, and safety of plasma-derived products, improving their therapeutic efficacy and reducing the risk of infectious transmission. These advancements enable manufacturers to produce a wide range of plasma therapeutics, including immunoglobulins, coagulation factors, albumin, and protease inhibitors, to address diverse patient needs and disease indications. The continuous refinement of plasma fractionation processes reflects the market's commitment to quality, safety, and innovation in delivering life-saving therapies to patients worldwide.

Plasma Therapeutics Market Driver: Increasing Demand for Plasma-Derived Therapeutics in Rare Diseases and Immunodeficiency Disorders

The increasing demand for plasma-derived therapeutics in the treatment of rare diseases and immunodeficiency disorders is a significant driver fueling the growth of the Plasma Therapeutics market. Plasma-derived products play a crucial role in managing various medical conditions, including primary immunodeficiency diseases (PIDDs), hemophilia, von Willebrand disease, autoimmune disorders, and neurological conditions. As awareness of these rare diseases grows and diagnostic capabilities improve, there is a rising need for safe, effective, and reliable therapeutic options to address underlying immune deficiencies, bleeding disorders, and other complications. Plasma therapeutics, such as intravenous immunoglobulins (IVIG), clotting factors, and alpha-1 antitrypsin, provide patients with life-sustaining treatments, improve quality of life, and reduce healthcare burdens associated with chronic disease management. The increasing prevalence of rare diseases and immunodeficiency disorders, coupled with advancements in diagnosis and treatment algorithms, drives market demand for plasma-derived therapeutics and fosters innovation in therapeutic development and delivery.

Plasma Therapeutics Market Opportunity: Emerging Applications in Regenerative Medicine and Cell Therapy

The Market Opportunity for Plasma Therapeutics lies in its emerging applications in regenerative medicine and cell therapy. Plasma-derived components, such as platelet-rich plasma (PRP) and plasma-derived growth factors, contain bioactive molecules that promote tissue regeneration, wound healing, and immune modulation. PRP therapies, which involve the isolation and concentration of platelets and growth factors from autologous plasma, are increasingly utilized in orthopedic surgery, sports medicine, dermatology, and aesthetic procedures to enhance tissue repair and accelerate recovery. Additionally, plasma-derived biomaterials and extracellular vesicles hold promise as novel platforms for cell culture, tissue engineering, and targeted drug delivery in regenerative medicine applications. By leveraging the biological properties of plasma-derived components and exploring innovative approaches to product development and clinical translation, Plasma Therapeutics manufacturers can expand their product portfolios and capture new opportunities in the burgeoning field of regenerative medicine, driving market growth and differentiation.

Plasma Therapeutics Market Share Analysis: Blood Factors is the fastest growing market segment over the forecast period to 2030

Blood Factors stand out as the fast-growing segment within Plasma Therapeutics. This growth is primarily fueled by several factors. Firstly, advancements in medical research and technology have led to an increased understanding of the crucial role blood factors play in various therapeutic applications, such as clotting disorders and immune deficiencies. Moreover, the rising prevalence of conditions such as hemophilia and thrombophilia, coupled with an aging population, has expanded the demand for blood factor therapies. Additionally, ongoing efforts to enhance product safety, efficacy, and accessibility have further propelled the growth of this segment. As a result, Blood Factors present a promising avenue for innovation and investment within the field of Plasma Therapeutics, with significant potential to address unmet medical needs and improve patient outcomes.

Plasma Therapeutics Market Segmentation

By Product
Immunoglobulin
Albumin
Blood Factors
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Plasma Therapeutics Companies

ADMA Biologics Inc
Bio Products Laboratory Ltd
BIOPHARMA PLASMA
CSL Ltd
Emergent BioSolutions Inc
Evolve Biologics Inc
Grifols SA
Kamada Ltd
Kedrion Spa
Octapharma AG
Pfizer Inc
Prothya Biosolutions Netherlands BV
SK Discovery Co. Ltd
Takeda Pharmaceutical Co. Ltd
* List not Exhaustive

Reasons to Buy the Plasma Therapeutics Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Plasma Therapeutics Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Plasma Therapeutics Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Plasma Therapeutics Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Plasma Therapeutics Market Size Outlook, $ Million, 2021 to 2030
3.2 Plasma Therapeutics Market Outlook by Type, $ Million, 2021 to 2030
3.3 Plasma Therapeutics Market Outlook by Product, $ Million, 2021 to 2030
3.4 Plasma Therapeutics Market Outlook by Application, $ Million, 2021 to 2030
3.5 Plasma Therapeutics Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Plasma Therapeutics Industry
4.2 Key Market Trends in Plasma Therapeutics Industry
4.3 Potential Opportunities in Plasma Therapeutics Industry
4.4 Key Challenges in Plasma Therapeutics Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Plasma Therapeutics Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Plasma Therapeutics Market Outlook by Segments
7.1 Plasma Therapeutics Market Outlook by Segments, $ Million, 2021- 2030
By Product
Immunoglobulin
Albumin
Blood Factors
Others
8 North America Plasma Therapeutics Market Analysis and Outlook To 2030
8.1 Introduction to North America Plasma Therapeutics Markets in 2024
8.2 North America Plasma Therapeutics Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Plasma Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Immunoglobulin
Albumin
Blood Factors
Others
9 Europe Plasma Therapeutics Market Analysis and Outlook To 2030
9.1 Introduction to Europe Plasma Therapeutics Markets in 2024
9.2 Europe Plasma Therapeutics Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Plasma Therapeutics Market Size Outlook by Segments, 2021-2030
By Product
Immunoglobulin
Albumin
Blood Factors
Others
10 Asia Pacific Plasma Therapeutics Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Plasma Therapeutics Markets in 2024
10.2 Asia Pacific Plasma Therapeutics Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Plasma Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Immunoglobulin
Albumin
Blood Factors
Others
11 South America Plasma Therapeutics Market Analysis and Outlook To 2030
11.1 Introduction to South America Plasma Therapeutics Markets in 2024
11.2 South America Plasma Therapeutics Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Plasma Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Immunoglobulin
Albumin
Blood Factors
Others
12 Middle East and Africa Plasma Therapeutics Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Plasma Therapeutics Markets in 2024
12.2 Middle East and Africa Plasma Therapeutics Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Plasma Therapeutics Market size Outlook by Segments, 2021-2030
By Product
Immunoglobulin
Albumin
Blood Factors
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ADMA Biologics Inc
Bio Products Laboratory Ltd
BIOPHARMA PLASMA
CSL Ltd
Emergent BioSolutions Inc
Evolve Biologics Inc
Grifols SA
Kamada Ltd
Kedrion Spa
Octapharma AG
Pfizer Inc
Prothya Biosolutions Netherlands BV
SK Discovery Co. Ltd
Takeda Pharmaceutical Co. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Immunoglobulin
Albumin
Blood Factors
Others